Latest Breaking News On - Aktiv pharma group - Page 1 : comparemela.com

Cybersecurity in health care 'truly takes a village'

Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer

SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 Kronos Bio, Inc. , a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by.

Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief

SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small.

Scopolamine Market is expected to Grow at US$ 675.6 Mn with 4.8% CAGR by 2030 | GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc. |

Colorado drugmaker to shutter operations

Aktiv Pharma Group, a drugmaker based in Broomfield, Colo., is planning to shut down two of its three plants and lay off 70 workers.